Drug intelligence / Profile preview

recombinant glucose-regulated protein 78

Development stage
Preclinical
Lead developer
Bio-Techne
Modality
Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

Recombinant glucose-regulated protein 78 (rGRP78) is a biotechnologically produced form of the 78-kDa glucose-regulated protein, a member of the heat shock protein 70 (HSP70) family that functions as a molecular chaperone in the endoplasmic reticulum (ER). While primarily located in the ER to assist in protein folding, GRP78 can be expressed on the cell surface (csGRP78) under conditions of cellular stress. In the context of cardiovascular research, rGRP78 is utilized as an experimental immunogen to induce the production of anti-GRP78 autoantibodies in animal models. These autoantibodies have been found to bind to csGRP78 on endothelial cells, triggering pro-inflammatory signaling pathways such as NF-κB and increasing the expression of adhesion molecules (ICAM-1, VCAM-1), which contributes to the progression of atherosclerosis.

Other names
recombinant GRP78recombinant BiPrecombinant HSPA5rGRP78rGRP-78rGRP 78recombinant 78 kDa glucose-regulated proteinrecombinant78 kDa glucose-regulated proteinrecombinant-78 kDa glucose-regulated protein
02

Targets

ATF6 (Activating transcription factor 6 alpha)ERN1 (Inositol-requiring enzyme 1 alpha)IgH (Immunoglobulin heavy chain)EIF2AK3 (Pkr-like endoplasmic reticulum kinase)DTMUV (Duck Tembusu virus)Unfolded/misfolded polypeptidesHSPA5 (Heat shock protein family A member 5)

Beyond the preview

Go deeper on recombinant glucose-regulated protein 78.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on recombinant glucose-regulated protein 78.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call